Page last updated: 2024-08-21

quinazolines and terazosin

quinazolines has been researched along with terazosin in 55 studies

Research

Studies (55)

TimeframeStudies, this research(%)All Research%
pre-19902 (3.64)18.7374
1990's11 (20.00)18.2507
2000's25 (45.45)29.6817
2010's14 (25.45)24.3611
2020's3 (5.45)2.80

Authors

AuthorsStudies
Kondo, S; Morita, T1
Kinami, J; Maruyama, K; Nagatomo, T; Tsuchihashi, H1
Nagatomo, T; Tsuchihashi, H1
Oates, HF1
Ferretti, S; Larosa, M; Salsi, P; Simonazzi, M1
Carter, AJ; Greengrass, PM; Kenny, BA; Naylor, AM; Read, AM; Wyllie, MG1
Benavides, J; Claustre, Y; Rouquier, L1
Cavallini, G1
Andersson, KE; Lepor, H; Wyllie, MG1
Fernández Arjona, M; Fernández Borrell, A; Gómez Sancha, F; Mínguez Martínez, R; Peinado Ibarra, F; Pereira Sanz, I1
Chapple, CR1
Suzuki, H1
Djavan, B; Marberger, M1
Fourcade, RO1
Clifford, GM; Farmer, RD1
de la ROSETTE, JJ; Floratos, DL; Kiemeney, LA; Kortmann, BB; Rossi, C; Sonke, GS; Wijkstra, H1
Cotecchia, S; Goepel, M; Hein, P; Michel, MC1
De la Rosette, JJ; Farmer, RD; Herings, RM; Leufkens, HG; Man in 't Veld, AJ; Souverein, PC1
Altenbach, RJ; Bai, H; Basha, FZ; Brune, ME; Buckner, SA; Carroll, WA; Drizin, I; Hancock, AA; Kerwin, JF; Lebold, SA; Lee, E; Meyer, MD; Pratt, JK; Sippy, KB; Tietje, K; Wendt, MD1
Benning, CM; Kyprianou, N1
de la Rosette, JJ; Floratos, DL; Kiemeney, LA; Kortmann, BB; Rossi, C; Sonke, GS1
Niu, CQ; Ren, LM1
Romics, I1
Kyprianou, N; Tahmatzopoulos, A1
Brown, GA; Sussman, DO1
Kyprianou, N; Rowland, RG; Tahmatzopoulos, A1
Hou, SK; Liu, SJ; Wang, XF; Wang, YC; Xu, KX1
Akbay, E; Bozlu, M; Cayan, S; Görür, S; Ulusoy, E1
Afshari, NA; Schwinn, DA1
Nagano, M; Osada, Y; Yamaguchi, T1
Michel, MC; Noguchi, Y; Ohtake, A; Okutsu, H; Sasamata, M; Someya, A; Suzuki, M; Ukai, M; Watanabe, M; Yanai-Inamura, H; Yuyama, H1
O'Leary, MP1
Albo, G; Berardi, F; Colabufo, NA; Contino, M; de Rienzo, G; Niso, M; Pagliarulo, A; Pagliarulo, V; Perrone, R1
Adayener, C; Akyol, I; Ates, F; Iseri, C; Senkul, T; Yilmaz, O1
Mamalis, N1
Bar-Yosef, Y; Kaver, I; Laufer, M; Mabjeesh, NJ; Matzkin, H; Neulander, EZ1
Chatterjee, M; Gupta, D; Gupta, S; Nanda, K; Ray, A; Singh, R; Tiwar, A1
Hoyano, Y; Kobayashi, S; Kusama, H; Maruyama, K; Tomiyama, Y; Yamazaki, Y1
Adomat, H; Elterman, DS; Fleshner, N; Guns, E; Hersey, K; Lawrentschuk, N; Wood, CA1
Chatziralli, IP; Sergentanis, TN1
Alan, C; Eren, AE; Ersay, AR; Ertung, Y; Kırılmaz, B; Koçoğlu, H1
Du, H; He, L; Ren, J; Wang, S1
Hill, TM; McEwen, C; Sherman, JJ; Welch, RW1
Ahmed, S; El Zohny, SA; Mohamed, NA1
Barkin, J; Berner, T; Diles, D; Franks, B1
Creta, M; Ficarra, V; Fusco, F; Giannarini, G; Longo, N; Mirone, V; Novara, G; Palmieri, A; Verze, P1
Anoopkumar-Dukie, S; Chess-Williams, R; Forbes, A; McDermott, C1
He, F; Li, GZ; Liu, N; Man, LB1
Hammad, MA; Omar, MA; Salman, BI2
Derayea, SM; Hammad, MA; Mohamed, AA; Mohamed, AI; Omar, MA1
Aboukhashaba, A; Fainberg, J; Gaffney, C; Kashanian, J; Khan, A; Pierce, H1
Hori, Y; Ohyama, K; Sugiura, M1
Dahm, P; Hwang, EC; Koziarz, A; Kuntz, GM; Oestreich, MC; Sathianathen, NJ; Scales, CD; Vernooij, RW1
Liu, L; Narayanan, NS; Pottegård, A; Simmering, JE; Welsh, MJ1

Reviews

14 review(s) available for quinazolines and terazosin

ArticleYear
Prostatic alpha 1-adrenoceptors and uroselectivity.
    The Prostate, 1997, Feb-15, Volume: 30, Issue:3

    Topics: Adrenergic alpha-Antagonists; Animals; Doxazosin; Humans; Male; Prazosin; Prostate; Quinazolines; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin

1997
[Alpha blockers in the treatment of benign hyperplasia of the prostate].
    Revista clinica espanola, 1997, Volume: 197, Issue:5

    Topics: Adrenergic alpha-Antagonists; Doxazosin; Humans; Indoramin; Male; Phenoxybenzamine; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin

1997
Pharmacotherapy for benign prostatic hyperplasia--the potential for alpha 1-adrenoceptor subtype-specific blockade.
    British journal of urology, 1998, Volume: 81 Suppl 1

    Topics: Adrenergic alpha-Antagonists; Clinical Trials as Topic; Doxazosin; Hormones; Humans; Male; Patient Selection; Plant Extracts; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin

1998
Treatment of benign prostatic hyperplasia and hypertension in elderly hypertensive patients.
    British journal of urology, 1998, Volume: 81 Suppl 1

    Topics: Adrenergic alpha-Antagonists; Aged; Female; Humans; Hypertension; Male; Multicenter Studies as Topic; Prazosin; Product Surveillance, Postmarketing; Prostatic Hyperplasia; Quinazolines; Randomized Controlled Trials as Topic

1998
A meta-analysis on the efficacy and tolerability of alpha1-adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction.
    European urology, 1999, Volume: 36, Issue:1

    Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Controlled Clinical Trials as Topic; Dizziness; Dose-Response Relationship, Drug; Doxazosin; Humans; Hypotension, Orthostatic; Male; Middle Aged; Prazosin; Prognosis; Prostatic Hyperplasia; Quinazolines; Treatment Outcome; Urologic Diseases

1999
Medical therapy for benign prostatic hyperplasia: a review of the literature.
    European urology, 2000, Volume: 38, Issue:1

    Topics: Adrenergic alpha-Antagonists; Doxazosin; Finasteride; Humans; Indoramin; Male; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin

2000
[Pharmacologic treatment of benign prostatic hyperplasia].
    Orvosi hetilap, 2003, Sep-14, Volume: 144, Issue:37

    Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Doxazosin; Enzyme Inhibitors; Finasteride; Humans; Male; Phytotherapy; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin

2003
Apoptotic impact of alpha1-blockers on prostate cancer growth: a myth or an inviting reality?
    The Prostate, 2004, Apr-01, Volume: 59, Issue:1

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Apoptosis; Doxazosin; Humans; Male; Prazosin; Prostatic Hyperplasia; Prostatic Neoplasms; Quinazolines

2004
The role of alpha-blockers in the management of prostate cancer.
    Expert opinion on pharmacotherapy, 2004, Volume: 5, Issue:6

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Angiogenesis Inhibitors; Anoikis; Doxazosin; Humans; Male; Prazosin; Prostatic Neoplasms; Quinazolines; Sulfonamides; Tamsulosin

2004
Treatment and pharmacologic management of BPH in the context of common comorbidities.
    The American journal of managed care, 2006, Volume: 12, Issue:5 Suppl

    Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Azasteroids; Cardiovascular Diseases; Comorbidity; Doxazosin; Drug Therapy, Combination; Dutasteride; Enzyme Inhibitors; Erectile Dysfunction; Finasteride; Global Health; Humans; Male; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin; Transurethral Resection of Prostate; Treatment Outcome

2006
[Alpha blockers in use for symptomatic benign prostatic hyperplasia--are all drugs born equal?].
    Harefuah, 2008, Volume: 147, Issue:6

    Topics: Adrenergic alpha-Antagonists; Doxazosin; Evidence-Based Medicine; Humans; Male; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin

2008
Risk factors for intraoperative floppy iris syndrome: a meta-analysis.
    Ophthalmology, 2011, Volume: 118, Issue:4

    Topics: Adrenergic alpha-1 Receptor Antagonists; Diabetes Complications; Doxazosin; Humans; Hypertension; Incidence; Intraoperative Complications; Iris; Iris Diseases; Odds Ratio; Phacoemulsification; Prazosin; Quinazolines; Risk Factors; Sulfonamides; Syndrome; Tamsulosin

2011
α1-Blockers Improve Benign Prostatic Obstruction in Men with Lower Urinary Tract Symptoms: A Systematic Review and Meta-analysis of Urodynamic Studies.
    European urology, 2016, Volume: 69, Issue:6

    Topics: Adrenergic alpha-1 Receptor Antagonists; Clinical Trials as Topic; Doxazosin; Humans; Indoles; Male; Naphthalenes; Piperazines; Prazosin; Prostatism; Quinazolines; Severity of Illness Index; Sulfonamides; Tamsulosin; Urodynamics

2016
Alpha-blockers after shock wave lithotripsy for renal or ureteral stones in adults.
    The Cochrane database of systematic reviews, 2020, 11-12, Volume: 11

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Chemotherapy, Adjuvant; Combined Modality Therapy; Doxazosin; Humans; Indoles; Kidney Calculi; Lithotripsy; Middle Aged; Prazosin; Quinazolines; Randomized Controlled Trials as Topic; Tamsulosin; Ureteral Calculi

2020

Trials

2 trial(s) available for quinazolines and terazosin

ArticleYear
Alpha-1 blockade pharmacotherapy in primitive psychogenic premature ejaculation resistant to psychotherapy.
    European urology, 1995, Volume: 28, Issue:2

    Topics: Adrenergic alpha-Antagonists; Adult; Cross-Over Studies; Double-Blind Method; Ejaculation; Humans; Male; Middle Aged; Prazosin; Psychotherapy; Quinazolines; Sexual Dysfunctions, Psychological

1995
[Efficiency and tolerance of terazosine in ambulatory patients with benign prostatic hypertrophy: comparative randomized and double-blind trial versus alfuzosin. The MG Terazosine Group].
    Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, 2000, Volume: 10, Issue:2

    Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Ambulatory Care; Double-Blind Method; Humans; Male; Prazosin; Prostatic Hyperplasia; Quality of Life; Quinazolines; Severity of Illness Index

2000

Other Studies

39 other study(ies) available for quinazolines and terazosin

ArticleYear
[Comparison of selective alpha-1 blockades for alpha-receptors in human hypertrophied prostatic adenomas].
    Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 1992, Volume: 83, Issue:3

    Topics: Adenoma; Adrenergic alpha-Antagonists; Aged; Humans; Male; Piperazines; Prazosin; Prostatic Hyperplasia; Prostatic Neoplasms; Quinazolines; Radioligand Assay; Receptors, Adrenergic, alpha

1992
Binding characteristics of alpha 1-adrenoceptors in bovine prostate using a radioligand binding assay.
    Journal of pharmacobio-dynamics, 1991, Volume: 14, Issue:6

    Topics: Adrenergic alpha-Antagonists; Animals; Cattle; Kinetics; Male; Membranes; Phentolamine; Prazosin; Prostate; Quinazolines; Radioligand Assay; Receptors, Adrenergic, alpha; Tritium

1991
Alpha-blocking potencies of antihypertensive agents (prazosin, terazosin, bunazosin, SGB-1534 and ketanserin) having with quinazoline or quinazolinedione as assessed by radioligand binding assay methods in rat brain.
    Journal of pharmacobio-dynamics, 1989, Volume: 12, Issue:3

    Topics: Adrenergic alpha-Antagonists; Animals; Antihypertensive Agents; Brain; Cell Membrane; Clonidine; Dihydroalprenolol; Ketanserin; Male; Prazosin; Quinazolines; Radioligand Assay; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta

1989
A new prazosin analogue, Abbott-45975 (A-45975)
    The New Zealand medical journal, 1981, Jul-22, Volume: 94, Issue:688

    Topics: Animals; Antihypertensive Agents; Prazosin; Quinazolines; Rats

1981
[Use of terazosin and alfuzosin in the treatment of benign prostatic hypertrophy (BPH): our experience].
    Acta bio-medica de L'Ateneo parmense : organo della Societa di medicina e scienze naturali di Parma, 1994, Volume: 65, Issue:1-2

    Topics: Adrenergic alpha-Antagonists; Aged; Follow-Up Studies; Humans; Male; Middle Aged; Prazosin; Prostatic Hyperplasia; Quinazolines; Time Factors

1994
Effect of alpha 1 adrenoceptor antagonists on prostatic pressure and blood pressure in the anesthetized dog.
    Urology, 1994, Volume: 44, Issue:1

    Topics: Adrenergic alpha-Antagonists; Affinity Labels; Anesthesia, Endotracheal; Animals; Blood Pressure; Dogs; Dose-Response Relationship, Drug; Doxazosin; Male; Models, Biological; Phenylephrine; Piperazines; Prazosin; Pressure; Prostate; Quinazolines; Sulfonamides; Tamsulosin

1994
Alpha 1-adrenoceptor antagonists differentially control serotonin release in the hippocampus and striatum: a microdialysis study.
    European journal of pharmacology, 1994, Aug-11, Volume: 261, Issue:1-2

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Extracellular Space; Hippocampus; Male; Microdialysis; Neostriatum; Perfusion; Prazosin; Quinazolines; Rats; Rats, Sprague-Dawley; Serotonin

1994
alpha-Blockade improves symptoms suggestive of bladder outlet obstruction but fails to relieve it.
    The Journal of urology, 2001, Volume: 165, Issue:1

    Topics: Adrenergic alpha-Antagonists; Humans; Male; Middle Aged; Prazosin; Quinazolines; Severity of Illness Index; Sulfonamides; Tamsulosin; Time Factors; Urinary Bladder Neck Obstruction; Urodynamics

2001
A quantitative analysis of antagonism and inverse agonism at wild-type and constitutively active hamster alpha1B-adrenoceptors.
    Naunyn-Schmiedeberg's archives of pharmacology, 2001, Volume: 363, Issue:1

    Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Cell Line; Chromones; Cricetinae; Dose-Response Relationship, Drug; Doxazosin; Fibroblasts; Inositol Phosphates; Phenethylamines; Prazosin; Quinazolines; Rats; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin; Tetralones; Tritium

2001
Evaluating adverse cardiovascular effects of drug treatment for benign prostatic hyperplasia (BPH): methodological considerations.
    Journal of clinical epidemiology, 2001, Volume: 54, Issue:5

    Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Adult; Aged; Bias; Cardiovascular Diseases; Case-Control Studies; Finasteride; Humans; Male; Middle Aged; Morbidity; Netherlands; Prazosin; Prognosis; Prostatic Hyperplasia; Quinazolines; Research Design; Risk Factors; Sulfonamides; Tamsulosin

2001
Structure-activity studies for a novel series of bicyclic substituted hexahydrobenz[e]isoindole alpha1A adrenoceptor antagonists as potential agents for the symptomatic treatment of benign prostatic hyperplasia.
    Journal of medicinal chemistry, 2001, Jun-07, Volume: 44, Issue:12

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Cell Line; Dogs; Doxazosin; Drug Design; Humans; Indicators and Reagents; Indoles; Isoindoles; L Cells; Male; Mice; Models, Molecular; Molecular Conformation; Prazosin; Prostate; Prostatic Hyperplasia; Quinazolines; Radioligand Assay; Rats; Receptors, Adrenergic, alpha-1; Recombinant Proteins; Spleen; Structure-Activity Relationship; Vas Deferens

2001
Quinazoline-derived alpha1-adrenoceptor antagonists induce prostate cancer cell apoptosis via an alpha1-adrenoceptor-independent action.
    Cancer research, 2002, Jan-15, Volume: 62, Issue:2

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Apoptosis; Dose-Response Relationship, Drug; Doxazosin; Humans; Male; Prazosin; Prostatic Neoplasms; Quinazolines; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin; Tumor Cells, Cultured

2002
Long-term risk of re-treatment of patients using alpha-blockers for lower urinary tract symptoms.
    The Journal of urology, 2002, Volume: 167, Issue:4

    Topics: Adrenergic beta-Antagonists; Follow-Up Studies; Humans; Male; Middle Aged; Prazosin; Prostatic Hyperplasia; Quinazolines; Risk Factors; Sulfonamides; Tamsulosin; Time Factors; Treatment Failure

2002
[Chiral separation and preparation of three new antagonists of alpha 1-adrenoceptors by chiral mobile phase HPLC].
    Yao xue xue bao = Acta pharmaceutica Sinica, 2002, Volume: 37, Issue:6

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Chromatography, High Pressure Liquid; Doxazosin; Molecular Structure; Prazosin; Quinazolines

2002
A current review of medical therapy for benign prostatic hyperplasia.
    The Journal of the American Osteopathic Association, 2004, Volume: 104, Issue:2 Suppl 2

    Topics: Adrenergic alpha-Antagonists; Algorithms; Azasteroids; Cholestenone 5 alpha-Reductase; Doxazosin; Drug Therapy, Combination; Dutasteride; Finasteride; Humans; Male; Prazosin; Prostatic Hyperplasia; Quinazolines; Urination Disorders

2004
[The growth inhibition effect of alpha-adrenoceptor antagonists on androgen- independent prostate cancer cell line].
    Zhonghua wai ke za zhi [Chinese journal of surgery], 2004, May-22, Volume: 42, Issue:10

    Topics: Adrenergic alpha-Antagonists; Antineoplastic Agents; Cell Cycle; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Humans; Male; Phenoxybenzamine; Prazosin; Prostatic Neoplasms; Quinazolines

2004
A comparison of four different alpha1-blockers in benign prostatic hyperplasia patients with and without diabetes.
    Scandinavian journal of urology and nephrology, 2004, Volume: 38, Issue:5

    Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Cohort Studies; Diabetes Mellitus; Doxazosin; Follow-Up Studies; Humans; Male; Middle Aged; Prazosin; Probability; Prostatic Hyperplasia; Quinazolines; Reference Values; Retrospective Studies; Risk Assessment; Severity of Illness Index; Sulfonamides; Tamsulosin; Treatment Outcome; Urination Disorders; Urodynamics

2004
Alpha1-adrenergic antagonists and floppy iris syndrome: tip of the iceberg?
    Ophthalmology, 2005, Volume: 112, Issue:12

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Doxazosin; Humans; Intraoperative Complications; Iris Diseases; Phacoemulsification; Prazosin; Pupil; Quinazolines; Sulfonamides; Syndrome; Tamsulosin

2005
Effects of different alpha-1 adrenoceptor blockers on proximal urethral function using in vivo isovolumetric pressure changes.
    Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi, 2005, Volume: 41, Issue:5

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Blood Pressure; Cardiovascular System; Male; Phenylephrine; Prazosin; Quinazolines; Rabbits; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin; Urethra

2005
In vivo studies on the effects of alpha1-adrenoceptor antagonists on pupil diameter and urethral tone in rabbits.
    Naunyn-Schmiedeberg's archives of pharmacology, 2006, Volume: 372, Issue:5

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Dose-Response Relationship, Drug; Doxazosin; Male; Prazosin; Pupil; Quinazolines; Rabbits; Receptors, Adrenergic, alpha-1; Time Factors; Urethra

2006
Human epididymal and prostatic tracts of vas deferens: different contraction response to noradrenaline stimulation in isolated organ bath assay.
    European journal of pharmacology, 2007, Dec-22, Volume: 577, Issue:1-3

    Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-Agonists; Aged; Dose-Response Relationship, Drug; Doxazosin; Epididymis; Humans; In Vitro Techniques; Male; Middle Aged; Muscle Contraction; Muscle, Smooth; Norepinephrine; Organ Specificity; Prazosin; Prostate; Quinazolines; Stimulation, Chemical; Vas Deferens

2007
Comparing the therapeutic outcome of different alpha-blocker treatments for BPH in the same individuals.
    International urology and nephrology, 2008, Volume: 40, Issue:3

    Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Humans; Male; Middle Aged; Prazosin; Prostate-Specific Antigen; Prostatic Hyperplasia; Quinazolines; Treatment Outcome

2008
Intraoperative floppy-iris syndrome associated with systemic alpha blockers.
    Journal of cataract and refractive surgery, 2008, Volume: 34, Issue:7

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Cataract Extraction; Doxazosin; Humans; Intraoperative Complications; Iris Diseases; Male; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Syndrome; Tamsulosin

2008
Functional screening of adrenergic receptors by measuring intracellular calcium using the FlexStation scanning fluorimeter.
    Biotechnology journal, 2009, Volume: 4, Issue:3

    Topics: Animals; Biotechnology; Calcium; Cell Line; Dose-Response Relationship, Drug; Fluorescent Dyes; Fluorometry; GTP-Binding Proteins; Humans; Kinetics; Prazosin; Protein Binding; Quinazolines; Receptors, Adrenergic; Signal Transduction; Sulfonamides; Tamsulosin

2009
Effects of four different alpha(1)-adrenoceptor antagonists on alpha-adrenoceptor agonist-induced contractions in isolated mouse and hamster ureters.
    Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi, 2009, Volume: 45, Issue:4

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Cricetinae; Doxazosin; Indoles; Male; Mesocricetus; Mice; Mice, Inbred ICR; Muscle Contraction; Norepinephrine; Prazosin; Quinazolines; Ureter

2009
Investigating contamination of phytotherapy products for benign prostatic hyperplasia with alpha-blockers and 5alpha-reductase inhibitors.
    The Journal of urology, 2010, Volume: 183, Issue:5

    Topics: Administration, Oral; Adrenergic alpha-Antagonists; Azasteroids; Capsules; Cholestenone 5 alpha-Reductase; Chromatography, High Pressure Liquid; Doxazosin; Drug Contamination; Dutasteride; Enzyme Inhibitors; Finasteride; Humans; Male; Phytotherapy; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tablets; Tamsulosin

2010
Comparison of effects of alpha receptor blockers on endothelial functions and coagulation parameters in patients with benign prostatic hyperplasia.
    Urology, 2011, Volume: 77, Issue:6

    Topics: Adrenergic alpha-Antagonists; Aged; Blood Coagulation; Blood Pressure; Brachial Artery; Doxazosin; Endothelial Cells; Endothelium, Vascular; Humans; Male; Middle Aged; Prazosin; Prostate-Specific Antigen; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin; Ultrasonography

2011
Cell membrane chromatography competitive binding analysis for characterization of α1A adrenoreceptor binding interactions.
    Analytical and bioanalytical chemistry, 2011, Volume: 400, Issue:10

    Topics: Adrenergic alpha-1 Receptor Antagonists; Binding, Competitive; Cell Line; Cell Membrane; Chromatography; Doxazosin; Humans; Methods; Phentolamine; Piperazines; Prazosin; Protein Binding; Quinazolines; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin

2011
Prescriber monitoring for benign prostatic hyperplasia within a family medicine clinic: a comparison of medication classes.
    Journal of pharmacy practice, 2012, Volume: 25, Issue:2

    Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Aged; Doxazosin; Drug Therapy, Combination; Family Practice; Humans; Indoles; Male; Middle Aged; Practice Patterns, Physicians'; Prazosin; Prostatic Hyperplasia; Quinazolines; Retrospective Studies; Sulfonamides; Tamsulosin

2012
Rapid and sensitive online determination of some selective α1-blockers by flow injection analysis with micelle-enhanced fluorescence detection.
    Journal of fluorescence, 2013, Volume: 23, Issue:6

    Topics: Adrenergic alpha-1 Receptor Antagonists; Doxazosin; Flow Injection Analysis; Fluorescence; Internet; Micelles; Prazosin; Quinazolines; Spectrometry, Fluorescence; Time Factors

2013
Alpha blocker monotherapy versus combination therapy with antimuscarinics in men with persistent LUTS refractory to alpha-adrenergic treatment: patterns of persistence.
    The Canadian journal of urology, 2015, Volume: 22, Issue:4

    Topics: Administrative Claims, Healthcare; Adrenergic alpha-Antagonists; Aged; Benzofurans; Doxazosin; Drug Therapy, Combination; Humans; Longitudinal Studies; Male; Mandelic Acids; Medication Adherence; Middle Aged; Muscarinic Antagonists; Ontario; Prazosin; Prostatic Hyperplasia; Prostatism; Pyrrolidines; Quinazolines; Retrospective Studies; Solifenacin Succinate; Sulfonamides; Tamsulosin; Tolterodine Tartrate

2015
Relative cytotoxic potencies and cell death mechanisms of α1 -adrenoceptor antagonists in prostate cancer cell lines.
    The Prostate, 2016, Volume: 76, Issue:8

    Topics: Adrenergic alpha-1 Receptor Antagonists; Antineoplastic Agents; Apoptosis; Autophagy; Cell Death; Cell Line, Tumor; Cell Survival; Doxazosin; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Indoles; Male; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Prazosin; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Quinazolines; Signal Transduction; Sulfonamides; Tamsulosin

2016
Efficacy of α-blocker in improving ureteral stent-related symptoms: a meta-analysis of both direct and indirect comparison.
    Drug design, development and therapy, 2016, Volume: 10

    Topics: Adrenergic alpha-Antagonists; Humans; Pain Measurement; Pain, Postoperative; Prazosin; Quinazolines; Stents; Treatment Outcome; Ureteral Obstruction

2016
Utility of Hantzsch reaction for development of highly sensitive spectrofluorimetric method for determination of alfuzosin and terazosin in bulk, dosage forms and human plasma.
    Luminescence : the journal of biological and chemical luminescence, 2017, Volume: 32, Issue:6

    Topics: Adrenergic alpha-1 Receptor Antagonists; Dosage Forms; Humans; Plasma; Prazosin; Quinazolines; Spectrometry, Fluorescence

2017
An efficient spectrofluorimetric method adopts doxazosin, terazosin and alfuzosin coupling with orthophthalaldehyde: Application in human plasma.
    Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 2018, Apr-15, Volume: 195

    Topics: Doxazosin; Fluorescence; Humans; Limit of Detection; o-Phthalaldehyde; Plasma; Prazosin; Quinazolines; Spectrometry, Fluorescence

2018
Micellar enhanced spectrofluorimetric approach for nanogram detection of certain α
    Luminescence : the journal of biological and chemical luminescence, 2018, Volume: 33, Issue:7

    Topics: Adrenergic alpha-1 Receptor Antagonists; Antihypertensive Agents; Doxazosin; Fluorescence; Humans; Limit of Detection; Micelles; Pharmaceutical Preparations; Plasma; Prazosin; Quinazolines; Spectrometry, Fluorescence; Tablets

2018
Postorgasmic illness syndrome: potential new treatment options for a rare disorder.
    Scandinavian journal of urology, 2020, Volume: 54, Issue:1

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Humans; Male; Orgasm; Prazosin; Quinazolines; Sexual Dysfunction, Physiological; Syndrome

2020
Evaluation of syncope association with α
    Die Pharmazie, 2019, 12-01, Volume: 74, Issue:12

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Doxazosin; Humans; Hypertension; Indoles; Male; Middle Aged; Prazosin; Prostatic Hyperplasia; Quinazolines; Syncope; Tamsulosin

2019
Association of Glycolysis-Enhancing α-1 Blockers With Risk of Developing Parkinson Disease.
    JAMA neurology, 2021, 04-01, Volume: 78, Issue:4

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Aged; Aged, 80 and over; Cohort Studies; Databases, Factual; Denmark; Doxazosin; Female; Follow-Up Studies; Glycolysis; Humans; Male; Middle Aged; Parkinson Disease; Prazosin; Quinazolines; Registries; Risk Factors; Tamsulosin; United States

2021